...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Webcast thoughts
Pretty good. I think the FDA wanted a bigger trial so they have likely resubmitted the new design. They are still targeting an H2 start. Don thinks there is lots of room for gains from the $200 million market cap. He made a similar comment when we were trading at 50 cents :) They are publishing some epigemetic info later this year and announcing an orphan indication this quarter. Both are catalysts. Otherwise, it seems the slides keep getting more professional so hopefully the right message is getting out there. Bfw
Share
New Message
Please login to post a reply